More on RANI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+58.3% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Rani Therapeutics (NQ:RANI)
Delayed: 0.61 +0.02 (3.39%)
Prev. Close $0.59  
Open$0.60 
52 Wk High$ 
52 Wk Low$ 
Day High$0.61 
Day Low$0.59 
P/E N/A  
EPS$ 
Volume290,766 


Oct 13, 2026 04:05 PM Rani Therapeutics to Participate in the Chardan Healthcare Conference
Oct 6, 2026 07:07 AM H.C. Wainwright Reiterates Buy Rating on Rani Therapeutics (RANI)
Oct 5, 2026 08:04 AM FDA accepts Rani Therapeutics' RaniPill platform into emerging tech program
Oct 5, 2026 08:00 AM Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
Sep 29, 2026 04:43 PM Form 4 Rani Therapeutics Holdin For: Sep 27 Filed by: Imran Talat
Sep 29, 2026 04:36 PM Form 4 Rani Therapeutics Holdin For: Sep 27 Filed by: Javadi Alireza
Aug 21, 2026 06:59 AM H.C. Wainwright Reiterates Buy Rating on Rani Therapeutics (RANI)
Aug 18, 2026 07:12 AM Chardan Starts Rani Therapeutics (RANI) at Buy
Aug 14, 2026 04:50 PM Form SCHEDULE 13G/A Rani Therapeutics Holdin Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 13, 2026 04:18 PM Form 10-Q Rani Therapeutics Holdin For: Jun 30
View All Articles

Entities mentioned with RANI

View All Entities